img

Pharmacovigilance (PV)


Published on: 2024-01-04 | No of Pages : 137 | Industry : Service & Software

Publisher : MRA | Format : PDF&Excel

Pharmacovigilance (PV)

The research team projects that the Pharmacovigilance (PV) market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2022 to 2027.



By Market Players

Accenture

Clinquest Group B.V.

Cognizant

Laboratory Corporation of America Holdings

IBM Corporation

ArisGlobal

ICON plc.

Capgemini

ITClinical

iMEDGlobal

Foresight Group International AG

TAKE Solutions Ltd.

PAREXEL International Corporation

BioClinica

Wipro Ltd.

United BioSource Corporation



By Type

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining



By Application

Hospitals

Research Organizations

Industrial







Points Covered in The Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.

The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.



The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Pharmacovigilance (PV) 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Market Analysis by Product TypeThe report covers majority Product Types in the Pharmacovigilance (PV) Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).

Markat Analysis by Application TypeBased on the Pharmacovigilance (PV) Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report will provide with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



COVID-19 Impact

Report covers Impact of Coronavirus COVID-19Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmacovigilance (PV) market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Pharmacovigilance (PV) Revenue

1.4 Market Analysis by Type

1.4.1 Global Pharmacovigilance (PV) Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Spontaneous Reporting

1.4.3 Intensified ADR Reporting

1.4.4 Targeted Spontaneous Reporting

1.4.5 Cohort Event Monitoring

1.4.6 EHR Mining

1.5 Market by Application

1.5.1 Global Pharmacovigilance (PV) Market Share by Application: 2022-2027

1.5.2 Hospitals

1.5.3 Research Organizations

1.5.4 Industrial

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Pharmacovigilance (PV) Market Perspective (2022-2027)

2.2 Pharmacovigilance (PV) Growth Trends by Regions

2.2.1 Pharmacovigilance (PV) Market Size by Regions: 2016 VS 2022 VS 2027

2.2.2 Pharmacovigilance (PV) Historic Market Size by Regions (2016-2021)

2.2.3 Pharmacovigilance (PV) Forecasted Market Size by Regions (2022-2027)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Pharmacovigilance (PV) Market Growth Strategy

3 Market Competition by Manufacturers

3.1 Global Pharmacovigilance (PV) Production Capacity Market Share by Manufacturers (2016-2021)

3.2 Global Pharmacovigilance (PV) Revenue Market Share by Manufacturers (2016-2021)

3.3 Global Pharmacovigilance (PV) Average Price by Manufacturers (2016-2021)

3.4 Manufacturers Pharmacovigilance (PV) Production Sites, Area Served, Product Type

4 Pharmacovigilance (PV) Sales Market by Type (2016-2027)

4.1 Global Pharmacovigilance (PV) Historic Market Size by Type (2016-2021)

4.2 Global Pharmacovigilance (PV) Forecasted Market Size by Type (2022-2027)

5 Pharmacovigilance (PV) Consumption Market by Application(2016-2027)

5.1 Global Pharmacovigilance (PV) Historic Market Size by Application (2016-2021)

5.2 Global Pharmacovigilance (PV) Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Pharmacovigilance (PV) Market Size (2016-2027)

6.2 Pharmacovigilance (PV) Key Players in North America (2016-2021)

6.3 North America Pharmacovigilance (PV) Market Size by Type (2016-2021)

6.4 North America Pharmacovigilance (PV) Market Size by Application (2016-2021)

7 East Asia

7.1 East Asia Pharmacovigilance (PV) Market Size (2016-2027)

7.2 Pharmacovigilance (PV) Key Players in East Asia (2016-2021)

7.3 East Asia Pharmacovigilance (PV) Market Size by Type (2016-2021)

7.4 East Asia Pharmacovigilance (PV) Market Size by Application (2016-2021)

8 Europe

8.1 Europe Pharmacovigilance (PV) Market Size (2016-2027)

8.2 Pharmacovigilance (PV) Key Players in Europe (2016-2021)

8.3 Europe Pharmacovigilance (PV) Market Size by Type (2016-2021)

8.4 Europe Pharmacovigilance (PV) Market Size by Application (2016-2021)

9 South Asia

9.1 South Asia Pharmacovigilance (PV) Market Size (2016-2027)

9.2 Pharmacovigilance (PV) Key Players in South Asia (2016-2021)

9.3 South Asia Pharmacovigilance (PV) Market Size by Type (2016-2021)

9.4 South Asia Pharmacovigilance (PV) Market Size by Application (2016-2021)

10 Southeast Asia

10.1 Southeast Asia Pharmacovigilance (PV) Market Size (2016-2027)

10.2 Pharmacovigilance (PV) Key Players in Southeast Asia (2016-2021)

10.3 Southeast Asia Pharmacovigilance (PV) Market Size by Type (2016-2021)

10.4 Southeast Asia Pharmacovigilance (PV) Market Size by Application (2016-2021)

11 Middle East

11.1 Middle East Pharmacovigilance (PV) Market Size (2016-2027)

11.2 Pharmacovigilance (PV) Key Players in Middle East (2016-2021)

11.3 Middle East Pharmacovigilance (PV) Market Size by Type (2016-2021)

11.4 Middle East Pharmacovigilance (PV) Market Size by Application (2016-2021)

12 Africa

12.1 Africa Pharmacovigilance (PV) Market Size (2016-2027)

12.2 Pharmacovigilance (PV) Key Players in Africa (2016-2021)

12.3 Africa Pharmacovigilance (PV) Market Size by Type (2016-2021)

12.4 Africa Pharmacovigilance (PV) Market Size by Application (2016-2021)

13 Oceania

13.1 Oceania Pharmacovigilance (PV) Market Size (2016-2027)

13.2 Pharmacovigilance (PV) Key Players in Oceania (2016-2021)

13.3 Oceania Pharmacovigilance (PV) Market Size by Type (2016-2021)

13.4 Oceania Pharmacovigilance (PV) Market Size by Application (2016-2021)

14 South America

14.1 South America Pharmacovigilance (PV) Market Size (2016-2027)

14.2 Pharmacovigilance (PV) Key Players in South America (2016-2021)

14.3 South America Pharmacovigilance (PV) Market Size by Type (2016-2021)

14.4 South America Pharmacovigilance (PV) Market Size by Application (2016-2021)

15 Rest of the World

15.1 Rest of the World Pharmacovigilance (PV) Market Size (2016-2027)

15.2 Pharmacovigilance (PV) Key Players in Rest of the World (2016-2021)

15.3 Rest of the World Pharmacovigilance (PV) Market Size by Type (2016-2021)

15.4 Rest of the World Pharmacovigilance (PV) Market Size by Application (2016-2021)

16 Company Profiles and Key Figures in Pharmacovigilance (PV) Business

16.1 Accenture

16.1.1 Accenture Company Profile

16.1.2 Accenture Pharmacovigilance (PV) Product Specification

16.1.3 Accenture Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.2 Clinquest Group B.V.

16.2.1 Clinquest Group B.V. Company Profile

16.2.2 Clinquest Group B.V. Pharmacovigilance (PV) Product Specification

16.2.3 Clinquest Group B.V. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.3 Cognizant

16.3.1 Cognizant Company Profile

16.3.2 Cognizant Pharmacovigilance (PV) Product Specification

16.3.3 Cognizant Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.4 Laboratory Corporation of America Holdings

16.4.1 Laboratory Corporation of America Holdings Company Profile

16.4.2 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Product Specification

16.4.3 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.5 IBM Corporation

16.5.1 IBM Corporation Company Profile

16.5.2 IBM Corporation Pharmacovigilance (PV) Product Specification

16.5.3 IBM Corporation Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.6 ArisGlobal

16.6.1 ArisGlobal Company Profile

16.6.2 ArisGlobal Pharmacovigilance (PV) Product Specification

16.6.3 ArisGlobal Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.7 ICON plc.

16.7.1 ICON plc. Company Profile

16.7.2 ICON plc. Pharmacovigilance (PV) Product Specification

16.7.3 ICON plc. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.8 Capgemini

16.8.1 Capgemini Company Profile

16.8.2 Capgemini Pharmacovigilance (PV) Product Specification

16.8.3 Capgemini Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.9 ITClinical

16.9.1 ITClinical Company Profile

16.9.2 ITClinical Pharmacovigilance (PV) Product Specification

16.9.3 ITClinical Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.10 iMEDGlobal

16.10.1 iMEDGlobal Company Profile

16.10.2 iMEDGlobal Pharmacovigilance (PV) Product Specification

16.10.3 iMEDGlobal Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.11 Foresight Group International AG

16.11.1 Foresight Group International AG Company Profile

16.11.2 Foresight Group International AG Pharmacovigilance (PV) Product Specification

16.11.3 Foresight Group International AG Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.12 TAKE Solutions Ltd.

16.12.1 TAKE Solutions Ltd. Company Profile

16.12.2 TAKE Solutions Ltd. Pharmacovigilance (PV) Product Specification

16.12.3 TAKE Solutions Ltd. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.13 PAREXEL International Corporation

16.13.1 PAREXEL International Corporation Company Profile

16.13.2 PAREXEL International Corporation Pharmacovigilance (PV) Product Specification

16.13.3 PAREXEL International Corporation Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.14 BioClinica

16.14.1 BioClinica Company Profile

16.14.2 BioClinica Pharmacovigilance (PV) Product Specification

16.14.3 BioClinica Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.15 Wipro Ltd.

16.15.1 Wipro Ltd. Company Profile

16.15.2 Wipro Ltd. Pharmacovigilance (PV) Product Specification

16.15.3 Wipro Ltd. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.16 United BioSource Corporation

16.16.1 United BioSource Corporation Company Profile

16.16.2 United BioSource Corporation Pharmacovigilance (PV) Product Specification

16.16.3 United BioSource Corporation Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer



List of Figure

Table 1. Key Players Covered: Ranking by Pharmacovigilance (PV) Revenue (US$ Million) 2016-2021

Table 2. Global Pharmacovigilance (PV) Market Size by Type (US$ Million): 2022-2027

Table 3. Global Pharmacovigilance (PV) Market Size by Application (US$ Million): 2022-2027

Table 4. Global Pharmacovigilance (PV) Market Size by Regions (US$ Million): 2022-2027

Table 5. Global Pharmacovigilance (PV) Market Size by Regions (2016-2021) (US$ Million)

Table 6. Global Pharmacovigilance (PV) Market Share by Regions (2016-2021)

Table 7. Global Pharmacovigilance (PV) Forecasted Market Size by Regions (2022-2027) (US$ Million)

Table 8. Global Pharmacovigilance (PV) Market Share by Regions (2022-2027)

Table 9. Market Top Trends

Table 10. Key Drivers: Impact Analysis

Table 11. Key Challenges

Table 12. Pharmacovigilance (PV) Market Growth Strategy

Table 13. Global Pharmacovigilance (PV) Production Capacity by Manufacturers

Table 14. Global Pharmacovigilance (PV) Production by Manufacturers (2016-2021)

Table 15. Global Pharmacovigilance (PV) Production Market Share by Manufacturers (2016-2021)

Table 16. Global Pharmacovigilance (PV) Revenue by Manufacturers (2016-2021)

Table 17. Global Pharmacovigilance (PV) Revenue Share by Manufacturers (2016-2021)

Table 18. Global Market Pharmacovigilance (PV) Average Price of Key Manufacturers (2016-2021)

Table 19. Manufacturers Pharmacovigilance (PV) Production Sites and Area Served

Table 20. Manufacturers Pharmacovigilance (PV) Product Type

Table 21. Global Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 22. Global Pharmacovigilance (PV) Revenue Market Share by Type (2016-2021)

Table 23. Global Pharmacovigilance (PV) Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 24. Global Pharmacovigilance (PV) Revenue Market Share by Type (2022-2027)

Table 25. Global Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 26. Global Pharmacovigilance (PV) Revenue Market Share by Application (2016-2021)

Table 27. Global Pharmacovigilance (PV) Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 28. Global Pharmacovigilance (PV) Revenue Market Share by Application (2022-2027)

Table 29. North America Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 30. North America Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 31. North America Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 32. North America Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 33. North America Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 34. North America Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 35. East Asia Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 36. East Asia Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 37. East Asia Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 38. East Asia Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 39. East Asia Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 40. East Asia Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 41. Europe Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 42. Europe Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 43. Europe Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 44. Europe Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 45. Europe Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 46. Europe Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 47. South Asia Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 48. South Asia Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 49. South Asia Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 50. South Asia Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 51. South Asia Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 52. South Asia Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 53. Southeast Asia Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 54. Southeast Asia Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 55. Southeast Asia Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 56. Southeast Asia Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 57. Southeast Asia Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 58. Southeast Asia Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 59. Middle East Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 60. Middle East Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 61. Middle East Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 62. Middle East Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 63. Middle East Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 64. Middle East Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 65. Africa Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 66. Africa Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 67. Africa Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 68. Africa Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 69. Africa Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 70. Africa Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 71. Oceania Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 72. Oceania Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 73. Oceania Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 74. Oceania Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 75. Oceania Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 76. Oceania Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 77. South America Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 78. South America Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 79. South America Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 80. South America Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 81. South America Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 82. South America Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 83. Rest of the World Key Players Pharmacovigilance (PV) Revenue (2016-2021) (US$ Million)

Table 84. Rest of the World Key Players Pharmacovigilance (PV) Market Share (2016-2021)

Table 85. Rest of the World Pharmacovigilance (PV) Market Size by Type (2016-2021) (US$ Million)

Table 86. Rest of the World Pharmacovigilance (PV) Market Share by Type (2016-2021)

Table 87. Rest of the World Pharmacovigilance (PV) Market Size by Application (2016-2021) (US$ Million)

Table 88. Rest of the World Pharmacovigilance (PV) Market Share by Application (2016-2021)

Table 89. Accenture Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 90. Clinquest Group B.V. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 91. Cognizant Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 92. Table Laboratory Corporation of America Holdings Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 93. IBM Corporation Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 94. ArisGlobal Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 95. ICON plc. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 96. Capgemini Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 97. ITClinical Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 98. iMEDGlobal Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 99. Foresight Group International AG Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 100. TAKE Solutions Ltd. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 101. PAREXEL International Corporation Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 102. BioClinica Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 103. Wipro Ltd. Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 104. United BioSource Corporation Pharmacovigilance (PV) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources





Figure 1. Global Pharmacovigilance (PV) Market Share by Type: 2021 VS 2027

Figure 2. Spontaneous Reporting Features

Figure 3. Intensified ADR Reporting Features

Figure 4. Targeted Spontaneous Reporting Features

Figure 5. Cohort Event Monitoring Features

Figure 6. EHR Mining Features

Figure 11. Global Pharmacovigilance (PV) Market Share by Application: 2021 VS 2027

Figure 12. Hospitals Case Studies

Figure 13. Research Organizations Case Studies

Figure 14. Industrial Case Studies

Figure 21. Pharmacovigilance (PV) Report Years Considered

Figure 22. Global Pharmacovigilance (PV) Market Size YoY Growth 2022-2027 (US$ Million)

Figure 23. Global Pharmacovigilance (PV) Market Share by Regions: 2022 VS 2027

Figure 24. Porter's Five Forces Analysis

Figure 25. North America Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 26. East Asia Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 27. Europe Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 28. South Asia Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 29. Southeast Asia Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 30. Middle East Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 31. Africa Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 32. Oceania Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 33. South America Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 34. Rest of the World Pharmacovigilance (PV) Market Size YoY Growth (2016-2027) (US$ Million)

Figure 35. Accenture Pharmacovigilance (PV) Product Specification

Figure 36. Clinquest Group B.V. Pharmacovigilance (PV) Product Specification

Figure 37. Cognizant Pharmacovigilance (PV) Product Specification

Figure 38. Laboratory Corporation of America Holdings Pharmacovigilance (PV) Product Specification

Figure 39. IBM Corporation Pharmacovigilance (PV) Product Specification

Figure 40. ArisGlobal Pharmacovigilance (PV) Product Specification

Figure 41. ICON plc. Pharmacovigilance (PV) Product Specification

Figure 42. Capgemini Pharmacovigilance (PV) Product Specification

Figure 43. ITClinical Pharmacovigilance (PV) Product Specification

Figure 44. iMEDGlobal Pharmacovigilance (PV) Product Specification

Figure 45. Foresight Group International AG Pharmacovigilance (PV) Product Specification

Figure 46. TAKE Solutions Ltd. Pharmacovigilance (PV) Product Specification

Figure 47. PAREXEL International Corporation Pharmacovigilance (PV) Product Specification

Figure 48. BioClinica Pharmacovigilance (PV) Product Specification

Figure 49. Wipro Ltd. Pharmacovigilance (PV) Product Specification

Figure 50. United BioSource Corporation Pharmacovigilance (PV) Product Specification

Figure 85. Key Executives Interviewed